In the heart of Miami's medical district, where the University of Miami Miller School of Medicine meets cutting-edge innovation, a healthcare revolution is quietly unfolding. Sylvester Comprehensive Cancer Center stands as South Florida's only NCI-designated cancer center, a distinction that places it among the nation's most elite oncology institutions. But this isn't just another medical facility—it's a powerhouse that's reshaping how we understand, treat, and ultimately defeat cancer.
Sylvester Comprehensive Cancer Center
South Florida's only NCI-Designated Cancer Center, delivering advanced cancer diagnostics, treatments, research, and community-responsive care. Committed to reducing the human burden of cancer through innovation and excellence.
View full profileThe center's influence extends far beyond its 13 locations across Miami-Dade and surrounding counties. With over 300 cancer-focused doctors and researchers conducting more than 430 clinical trials, according to umiamihealth.org, Sylvester has become a magnet for both breakthrough science and the patients who need it most. The numbers tell a compelling story: pancreatic cancer patients here achieve survival rates up to 14% higher than national averages, driven by specialized research that's pushing the boundaries of what's possible in oncology.
The Griffin Revolution: Doubling Down on Discovery
Fall 2025 marked a watershed moment for Sylvester with the opening of the Kenneth C. Griffin Cancer Research Building, a 244,000-square-foot facility that quite literally doubled the center's research footprint. According to Becker's Oncology, this architectural marvel houses clinical care for up to 1,000 staff members, featuring 27 infusion bays, state-of-the-art imaging suites, and AI-driven laboratories that represent the future of cancer research.
What sets the Griffin building apart isn't just its size—it's the philosophy behind its design. The facility features collaborative "neighborhood" labs that bring together researchers from different disciplines, fostering the kind of cross-pollination that leads to breakthrough discoveries. Beyond the high-tech laboratories, the building also houses supportive therapies including yoga and nutrition counseling, an onsite pharmacy, and even art and music therapy programs.
The Griffin Cancer Research Building represents the largest single expansion in Sylvester's history, positioning Miami as a major hub for oncology innovation in the southeastern United States.
Leadership Driving Innovation Forward
At the helm of this medical empire stands Dr. Stephen D. Nimer, whose vision for Sylvester extends well beyond traditional cancer care. As Director, Nimer has overseen the center's rapid expansion and its elevation to NCI-designated status in 2019. His recruitment strategy has attracted some of the nation's top oncology talent to Miami, including Dr. Jose Lutzky, the new Director of Cutaneous Oncology Services and Associate Director of Clinical Research, who brings over 120 publications to his role.
NCI recognizes that Sylvester is among the top cancer centers in the country, and this is helping us recruit top cancer experts.
The leadership team also includes Dr. Estelamari Rodriguez, Associate Director of Community Outreach for Thoracic Oncology, who focuses specifically on lung cancer in women—a specialization that reflects Sylvester's commitment to addressing cancer's diverse impacts across different populations.
Breaking Through in Pancreatic Cancer
Perhaps nowhere is Sylvester's impact more evident than in its approach to pancreatic cancer, traditionally one of the most challenging forms of the disease. The Sylvester Pancreatic Cancer Research Institute (SPCRI) recently completed a phase 3 clinical trial targeting KRAS mutations, a breakthrough that could fundamentally change treatment options for patients.
We think this may be the next big breakthrough in pancreatic cancer treatment.
The center's pancreatic cancer program has earned recognition from the Department of Defense, receiving a grant in August 2023 for continued research efforts. Meanwhile, an NCI grant from the same period supports development of a urine test that could significantly reduce the need for prostate cancer biopsies—innovations that showcase Sylvester's broad impact across multiple cancer types.
Fostering the Next Generation of Innovation
In January 2026, Sylvester took its commitment to innovation a step further by hosting a Life Sciences and Health Tech Innovation Ecosystem Summit. According to news.med.miami.edu, this gathering connected researchers, investors, and innovators from across the region, culminating in the launch of the $1 million Sylvester Innovates Fund.
- Advance early-stage oncology projects from laboratory to clinical application
- Support discussions on intellectual property strategies for medical innovations
- Foster startup development within the oncology space
- Create pathways for researcher-investor collaboration
This fund represents more than just financial support—it's a recognition that breakthrough cancer treatments often emerge from the intersection of academic research and entrepreneurial innovation. By providing a bridge between these worlds, Sylvester is positioning Miami as a launchpad for the next generation of cancer therapeutics.
Beyond Treatment: A Holistic Approach to Care
Sylvester's impact extends beyond traditional treatment modalities. The center recently launched RENEW, a 12-week lifestyle medicine weight loss program specifically designed for cancer survivors. This program reflects a growing understanding that cancer care doesn't end with treatment—it evolves into a comprehensive approach to helping survivors reclaim their health and quality of life.
The center's expansion into Naples in November 2023 made Sylvester the first NCI-designated cancer center with a presence in that market, according to umiamihealth.org press releases. This geographic expansion demonstrates how Miami-based healthcare excellence is extending its reach across South Florida, bringing world-class cancer care closer to patients who might otherwise face long travel distances.
The Economic Engine of Innovation
Sylvester's influence on Miami extends far beyond healthcare outcomes. With over 150 researchers and staff employed across its operations, the center represents a significant economic driver for the region. The opening of the Griffin Research Building alone created infrastructure that supports advanced biomedical research, attracting national funding for clinical trials and establishing Miami as a hub for southeastern United States cancer research.
| Milestone | Date | Impact |
|---|---|---|
| Griffin Building Opening | Fall 2025 | Doubles research space, houses 1,000 staff |
| Innovates Fund Launch | January 2026 | $1M for oncology projects |
| KRAS Phase 3 Trial | Recent completion | Targets pancreatic cancer mutations |
| Naples Expansion | November 2023 | First NCI center in Naples market |
The center's 13 locations across a four-county catchment area—including sites in Miami, Coral Gables, Coral Springs, Deerfield Beach, Doral, Fort Lauderdale, Hollywood, Kendall, Naples, North Miami, and Plantation—create a network that enhances local healthcare access while reducing travel burdens for patients throughout the region.
What's Next: The Future of Cancer Care in Miami
As Sylvester continues to expand its research capabilities and clinical offerings, the center is positioned to become an even more significant force in global cancer research. The combination of NCI designation, state-of-the-art facilities, world-class talent, and innovative funding mechanisms creates a foundation for sustained growth and impact.
With ongoing studies in multiple myeloma immunotherapy resistance and continued investment in early-stage research through the Innovates Fund, Sylvester is building a pipeline of discoveries that could reshape cancer treatment not just in Miami, but worldwide. The center's commitment to community involvement, prevention efforts, and education ensures that its impact extends beyond the laboratory and clinic into the broader South Florida community.
In a city known for its innovation in real estate, technology, and finance, Sylvester Comprehensive Cancer Center stands as proof that Miami's most important innovations may well be happening in the realm of healthcare. As the only NCI-designated cancer center in South Florida, it's not just treating patients—it's defining the future of cancer care for an entire region.
